24 results
424B5
ACRS
Aclaris Therapeutics Inc
10 Jun 21
Prospectus supplement for primary offering
4:26pm
or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 662∕3% of the outstanding voting stock … directors may call a special meeting of stockholders.
Our amended and restated bylaws also provide that stockholders seeking to present proposals before
424B5
ACRS
Aclaris Therapeutics Inc
8 Jun 21
Prospectus supplement for primary offering
4:25pm
at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 662∕3% of the outstanding voting … of authorized directors may call a special meeting of stockholders.
Our amended and restated bylaws also provide that stockholders seeking to present
S-3ASR
mhb707 xc
20 May 21
Automatic shelf registration
4:56pm
424B5
vkzqz5 nk
20 Jan 21
Prospectus supplement for primary offering
5:00pm
424B5
tx2eb3xri oyy2rf
19 Jan 21
Prospectus supplement for primary offering
4:04pm
424B5
jfcuzhg7f6yyan
13 Aug 20
Prospectus supplement for primary offering
5:26pm
8-K
EX-3.1
mmz n3jen9
24 Jun 20
Amendments to Articles of Incorporation or Bylaws
5:00pm
424B5
k0u05sq45st
29 Apr 20
Prospectus supplement for primary offering
4:03pm
424B5
7g9tj80sce1 f6rpzq
18 Oct 18
Prospectus supplement for primary offering
4:08pm
424B5
77od3
17 Oct 18
Prospectus supplement for primary offering
4:04pm